Wealthfront Advisers LLC Invests $2.77 Million in Xylem Inc. $XYL

Wealthfront Advisers LLC bought a new stake in Xylem Inc. (NYSE:XYL) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 23,447 shares of the industrial products company’s stock, valued at approximately $2,772,000.

A number of other large investors have also recently made changes to their positions in XYL. Callahan Advisors LLC purchased a new stake in Xylem in the 4th quarter valued at $1,721,000. Northwestern Mutual Wealth Management Co. grew its position in Xylem by 2,309.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 431,824 shares of the industrial products company’s stock worth $54,314,000 after purchasing an additional 413,904 shares during the last quarter. Abacus Wealth Partners LLC acquired a new position in Xylem in the fourth quarter valued at $1,663,000. Norges Bank purchased a new stake in shares of Xylem in the fourth quarter valued at about $361,012,000. Finally, Franklin Resources Inc. raised its holdings in shares of Xylem by 0.6% in the fourth quarter. Franklin Resources Inc. now owns 1,787,994 shares of the industrial products company’s stock valued at $243,489,000 after buying an additional 10,314 shares during the last quarter. 87.96% of the stock is owned by institutional investors and hedge funds.

Xylem Price Performance

XYL stock opened at $113.42 on Friday. The firm has a 50 day moving average of $117.96 and a 200-day moving average of $119.86. Xylem Inc. has a 12-month low of $105.29 and a 12-month high of $154.27. The company has a current ratio of 1.61, a quick ratio of 1.24 and a debt-to-equity ratio of 0.23. The company has a market cap of $26.48 billion, a price-to-earnings ratio of 27.00, a PEG ratio of 1.61 and a beta of 1.02.

Xylem (NYSE:XYL) last released its quarterly earnings results on Tuesday, July 28th. The industrial products company reported $1.46 earnings per share for the quarter, topping analysts’ consensus estimates of $1.34 by $0.12. Xylem had a return on equity of 11.77% and a net margin of 11.15%.The business had revenue of $2.34 billion for the quarter, compared to analysts’ expectations of $2.34 billion. During the same quarter in the prior year, the firm posted $1.26 EPS. The company’s revenue was up 1.5% compared to the same quarter last year. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. As a group, equities analysts expect that Xylem Inc. will post 5.67 EPS for the current fiscal year.

Xylem Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 24th. Shareholders of record on Thursday, August 27th will be issued a $0.43 dividend. The ex-dividend date of this dividend is Thursday, August 27th. This represents a $1.72 annualized dividend and a yield of 1.5%. Xylem’s dividend payout ratio is 40.95%.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the company. UBS Group boosted their price target on Xylem from $135.00 to $138.00 and gave the company a “neutral” rating in a research report on Thursday, August 13th. Royal Bank Of Canada increased their price objective on Xylem from $159.00 to $164.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 29th. Barclays boosted their target price on Xylem from $154.00 to $159.00 and gave the company an “overweight” rating in a report on Wednesday, July 29th. Stifel Nicolaus raised their target price on shares of Xylem from $157.00 to $160.00 and gave the stock a “buy” rating in a research note on Wednesday, July 29th. Finally, Oppenheimer dropped their price target on shares of Xylem from $160.00 to $158.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 29th. Nine investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $154.23.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.